FIELD: medicine. SUBSTANCE: method involves determining silicon contents in biologically active fluid. The deviation being greater than 50% from the concentration observable in healthy persons, the testee is recommended to pass full scale examination. EFFECT: early detection of oncological disease cases.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PROGNOSTICATION OF MAN'S HEALTH STATE | 1998 |
|
RU2140634C1 |
| METHOD TO PREDICT HUMAN BODY STATE | 1994 |
|
RU2110796C1 |
| METHOD FOR EVALUATING RADIATION EXPOSURE INFLUENCE ON HUMAN BEING HEALTH | 1998 |
|
RU2129715C1 |
| METHOD OF ESTIMATION OF EFFICIENCY OF THERAPEUTIC OR DESTRUCTIVE EFFECT ON MAN'S HEALTH | 1997 |
|
RU2115119C1 |
| METHOD OF DIAGNOSIS OF PULMONARY TUBERCULOSIS | 1997 |
|
RU2123276C1 |
| METHOD OF ESTIMATING GENERAL STATE OF HUMAN HEALTH | 1998 |
|
RU2128336C1 |
| METHOD FOR EVALUATING IMMUNE PROTECTION SYSTEM STATE | 2000 |
|
RU2163720C1 |
| METHOD OF SELECTING DRUG AND ITS DOSE | 1999 |
|
RU2154984C1 |
| AGENT AND A METHOD OF TREATMENT OF PATIENTS WITH TUBERCULOSIS | 1997 |
|
RU2119338C1 |
| METHOD FOR PREDICTING MALIGNANT NEOPLASM TO BE THE CASE | 1999 |
|
RU2157528C1 |
